Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis
Author:
R. Bartsch,J.M. Pérez-García,J. Furtner,A.S. Berghoff,M. Marhold,A.M. Starzer,M. Hughes,S. Kabraji,S. Sammons,C. Anders,R.K. Murthy,A.E.D. Van Swearingen,A. Pereslete,M. Gion,M. Vaz Batista,S. Braga,P.B.C. Pinto,M. Sampayo-Cordero et al.
© 2024 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.